Hospital Nacional Arzobispo Loayza

Lima Lima 1

1 studies enrolling now · 12 studies all time

What they study most

Acute Heart Failure (AHF), Advanced Cholangiocarcinoma, Amyloidosis, Bipolar Depression, Chronic Heart Failure, Estrogen Receptor-Positive, HER2-Negative Advanced Breast Cancer, FGFR2 Gene Rearrangements, HER2-Positive Primary Breast Cancer, Heart Failure, Idiopathic Focal Segmental Glomerulosclerosis, Influenza, Influenza and Other Novel Respiratory Viruses

Studies at this site

• A Study to Evaluate Efficacy and Safety of Giredestrant Compared With Fulvestrant (Plus a CDK4/6 Inhibitor), in Participants With ER-Positive, HER2-Negative Advanced Breast Cancer Resistant to Adjuvant Endocrine Therapy (pionERA Breast Cancer) — Recruiting now
• A Study of Trastuzumab Deruxtecan (T-DXd) Versus Trastuzumab Emtansine (T-DM1) in High-risk HER2-positive Participants With Residual Invasive Breast Cancer Following Neoadjuvant Therapy (DESTINY-Breast05) — Running, not enrolling
• American Registry of Ambulatory or Acutely Decompensated Heart Failure — Completed
• Futibatinib Versus Gemcitabine-Cisplatin Chemotherapy as First-Line Treatment of Patients With Advanced Cholangiocarcinoma Harboring FGFR2 Gene Rearrangements — Stopped early
• A Study of Ad26.COV2.S for the Prevention of SARS-CoV-2-Mediated COVID-19 in Adult Participants — Completed
• Respiratory Virus Hospitalization Study (FLU 003 Plus) — Completed
• Acthar for Treatment-Resistant or Treatment-Intolerant Proteinuria — Completed
• Efficacy and Safety Study of Laninamivir Octanoate TwinCaps® Dry Powder Inhaler in Adults With Influenza — Completed
• Respiratory Virus Outpatient Study (FLU 002 Plus) — Completed
• Lurasidone - A 24-week Extension Study of Patients With Bipolar I Depression — Completed
• Efficacy and Safety Study of KIACTA in Preventing Renal Function Decline in AA Amyloidosis — Completed
• Lurasidone HCI - A 6-week Phase 3 Study of Patients With Bipolar I Depression — Completed